OpenAI, X, Google can use legitimate interest for AI models, EDPB says
The following EU Law news provides comprehensive and up to date legal information on OpenAI, X, Google can use legitimate interest for AI models, EDPB says
Commercialisation
View Life Sciences by content type:
Sub Topics We Cover
Latest Life Sciences News
Featured Life Sciences content
Practice notes
Second and subsequent medical use patent claimsBackground to medical use claimsSecond (and subsequent) medical use patent claims are specific to the...
1st Mar
Practice notes
Post-market surveillance of medical devices in the EUPost-market surveillance is the monitoring by manufacturers of medical devices to ensure their...
Produced in partnership with Alison Dennis of Taylor Wessing LLP
1st Mar
Practice notes
Intellectual property protection for medical devicesChanges to intellectual property (IP) law from 1 January 2021Before discussing how intellectual...
Produced in partnership with Reuben E. Jacob of Maucher Jenkins and Dr Edward Rainsford of Maucher Jenkins
1st Mar
Practice notes
Medicines and Medical Devices Act 2021This Practice Note provides an overview of the Medicines and Medical Devices Act 2021 (MMDA 2021) which, in...
1st Mar
Brexit
Practice notes
Introduction to borderline productsThis Practice Note provides an introduction to the concept of borderline products, how the regulatory status of...
2nd Mar
Precedents
Clinical Research Organisation (CRO) master services agreementDATA PROTECTION NOTICE: Please note that the drafting of clause 7 (Data Protection), in...
1st Mar
Practice notes
PharmacovigilancePharmacovigilance is the process of collecting and understanding information relating to the adverse effects of medicinal product...
Produced in partnership with Eveline Van Keymeulen of Latham & Watkins and Jeanne Fabre of Latham & Watkins
2nd Mar
News
Life Sciences analysis: Peter Rudd-Clarke, partner, and Anna Lundy, associate director, at Osborne Clarke discuss how the medical device industry is...
2nd Mar
Precedents
Medical devices due diligence questionnaireIntroductionThis medical devices regulatory due diligence questionnaire relates to the proposed purchase by...
2nd Mar
News
This week's edition of Life Sciences weekly highlights includes analysis of the English court’s jurisdiction to decide COVID-related business...
2nd Mar
Practice notes
The regulation of advanced therapy medicinal productsThe development of medicine, biomicrobiology and biotechnology has led to the emergence of a...
Produced in partnership with Geneviève Michaux of King & Spalding
2nd Mar
Practice notes
The experimental use and Bolar-type exemptions to patent infringementPatent systems are intended to foster innovation, not to impede it. For this...
1st Mar
News
This week's edition of Life Sciences weekly highlights includes consideration of the arguments put forward against DeepMind, Google’s subsidiary, for...
2nd Mar
Practice notes
Pharma and medical device regulation—Colombia—Q&A guideThis Practice Note contains a jurisdiction-specific Q&A guide to pharma and medical device...
2nd Mar
Practice notes
Biotechnology patentsPatenting biotechnological inventionsBiotechnological inventions are, in principle, patentable. While there is no general...
1st Mar
Practice notes
The EU Clinical Trials RegulationThis Practice Note looks at Regulation (EU) 536/2014, the EU Clinical Trials Regulation (CTR), which governs clinical...
Produced in partnership with Eveline Van Keymeulen of Latham & Watkins
2nd Mar
CONTACT US
